[96a5a0]: / output / allTrials / identified / NCT01261962_identified.json

Download this file

304 lines (304 with data), 12.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
{
"info": {
"nct_id": "NCT01261962",
"official_title": "Modulation of Immune Response by Oral Zinc Supplementation in Adjuvant Chemotherapy for Colon Cancer: a Study of Global Gene Expression and Function of Humoral Immunity and Neutrophils",
"inclusion_criteria": "* Age greater than 18 years\n* Diagnostic histopathology of colon cancer stage III (Dukes' stage C)\n* Performance Scale Karnofsky greater or equal to 70%\n* Have been subjected to resection of the primary neoplastic lesion in more than 8 weeks before start of chemotherapy\n* Patient in the first cycle of chemotherapy in adjuvant XELOX regimen.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patients with a history of autoimmune or inflammatory disease, active infectious disease, liver disease, renal failure or diabetes mellitus\n* Patients with metastatic disease\n* Have previously received radiotherapy or chemotherapy\n* Use of GCSF-Granulokine ® (growth-stimulating factor granulocyte)\n* Use of immunosuppressive drugs, diuretics and supplements of zinc or copper.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Age greater than 18 years",
"criterions": [
{
"exact_snippets": "Age greater than 18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Diagnostic histopathology of colon cancer stage III (Dukes' stage C)",
"criterions": [
{
"exact_snippets": "Diagnostic histopathology of colon cancer",
"criterion": "colon cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "III (Dukes' stage C)"
}
]
}
]
},
{
"line": "* Performance Scale Karnofsky greater or equal to 70%",
"criterions": [
{
"exact_snippets": "Performance Scale Karnofsky greater or equal to 70%",
"criterion": "Karnofsky Performance Scale",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Have been subjected to resection of the primary neoplastic lesion in more than 8 weeks before start of chemotherapy",
"criterions": [
{
"exact_snippets": "resection of the primary neoplastic lesion",
"criterion": "resection of primary neoplastic lesion",
"requirements": [
{
"requirement_type": "time since procedure",
"expected_value": {
"operator": ">",
"value": 8,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Patient in the first cycle of chemotherapy in adjuvant XELOX regimen.",
"criterions": [
{
"exact_snippets": "first cycle of chemotherapy",
"criterion": "chemotherapy cycle",
"requirements": [
{
"requirement_type": "cycle number",
"expected_value": true
}
]
},
{
"exact_snippets": "adjuvant XELOX regimen",
"criterion": "chemotherapy regimen",
"requirements": [
{
"requirement_type": "regimen type",
"expected_value": "adjuvant XELOX"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients with a history of autoimmune or inflammatory disease, active infectious disease, liver disease, renal failure or diabetes mellitus",
"criterions": [
{
"exact_snippets": "history of autoimmune or inflammatory disease",
"criterion": "autoimmune or inflammatory disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "active infectious disease",
"criterion": "infectious disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": "active"
}
]
},
{
"exact_snippets": "liver disease",
"criterion": "liver disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "renal failure",
"criterion": "renal failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "diabetes mellitus",
"criterion": "diabetes mellitus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with metastatic disease",
"criterions": [
{
"exact_snippets": "metastatic disease",
"criterion": "metastatic disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Have previously received radiotherapy or chemotherapy",
"criterions": [
{
"exact_snippets": "previously received radiotherapy",
"criterion": "radiotherapy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "previously received ... chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Use of GCSF-Granulokine ® (growth-stimulating factor granulocyte)",
"criterions": [
{
"exact_snippets": "Use of GCSF-Granulokine ® (growth-stimulating factor granulocyte)",
"criterion": "GCSF-Granulokine ® (growth-stimulating factor granulocyte)",
"requirements": [
{
"requirement_type": "use",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Use of immunosuppressive drugs, diuretics and supplements of zinc or copper.",
"criterions": [
{
"exact_snippets": "Use of immunosuppressive drugs",
"criterion": "immunosuppressive drugs",
"requirements": [
{
"requirement_type": "use",
"expected_value": true
}
]
},
{
"exact_snippets": "use ... diuretics",
"criterion": "diuretics",
"requirements": [
{
"requirement_type": "use",
"expected_value": true
}
]
},
{
"exact_snippets": "use ... supplements of zinc",
"criterion": "zinc supplements",
"requirements": [
{
"requirement_type": "use",
"expected_value": true
}
]
},
{
"exact_snippets": "use ... supplements of ... copper",
"criterion": "copper supplements",
"requirements": [
{
"requirement_type": "use",
"expected_value": true
}
]
}
]
}
],
"failed_miscellaneous": []
}